Institut Català de la Salut
[De Francesch V] Child and Adolescent Neuropsychiatry Unit, AULSS1 Dolomiti, San Martino Hospital, Belluno, Italy. Grup de Recerca en Neurologia Pediàtrica, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. [Cazurro-Gutiérrez A] Grup de Recerca en Neurologia Pediàtrica, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Departament de Pediatria, d’Obstetrícia i Ginecologia, i Medicina Preventiva i Salut Pública, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Timmers ER] Expertise Centre Movement Disorders Groningen, Department of Neurology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. [Español-Martín G] Departament de Pediatria, d’Obstetrícia i Ginecologia, i Medicina Preventiva i Salut Pública, Universitat Autònoma de Barcelona, Bellaterra, Spain. Servei de Pediatria, Secció de Neurologia Pediàtrica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Biomedical Research Networking Center on Rare Diseases, Madrid, Spain. [Ferrero-Turrión J, Marcé-Grau A] Grup de Recerca en Neurologia Pediàtrica, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. [Gómez-Andrés D, Dougherty-de Miguel L, González V] Grup de Recerca en Neurologia Pediàtrica, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Servei de Pediatria, Secció de Neurologia Pediàtrica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Moreno-Galdó A] Departament de Pediatria, d’Obstetrícia i Ginecologia, i Medicina Preventiva i Salut Pública, Universitat Autònoma de Barcelona, Bellaterra, Spain. Servei de Pediatria, Secció de Neurologia Pediàtrica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Biomedical Research Networking Center on Mental Health, Madrid, Spain. [Pérez-Dueñas B] Grup de Recerca en Neurologia Pediàtrica, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Departament de Pediatria, d’Obstetrícia i Ginecologia, i Medicina Preventiva i Salut Pública, Universitat Autònoma de Barcelona, Bellaterra, Spain. Servei de Pediatria, Secció de Neurologia Pediàtrica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Biomedical Research Networking Center on Rare Diseases, Madrid, Spain. European Reference Network for Rare Neurological Diseases, Tübingen, Germany
Vall d'Hebron Barcelona Hospital Campus
2025-05-16T06:31:24Z
2025-05-16T06:31:24Z
2025-06
Myoclonus dystonia; Children
Distonía mioclónica; Niños
Distonia mioclònica; Nens
Aim: To investigate the natural progression of SGCE-associated myoclonus dystonia from symptom onset in childhood to early adulthood. Method: Myoclonus and dystonia were monitored using rating scales in two cohorts of participants from Spain and the Netherlands. Individual annualized rates of change were calculated and longitudinal trends were assessed using Bayesian mixed models. Psychiatric features were evaluated cross-sectionally in the Spanish cohort. Results: Thirty-eight patients (21 males, 17 females) were evaluated at a mean age (SD) of 10 years (4 years 7 months; range 2-21 years) and 14 years 2 months (4 years 8 months; range 4-25 years). We observed a significant worsening of action myoclonus, global dystonia, and dystonia during writing (mean annual increases of 1.356, 0.226, and 0.518 in the Unified Myoclonus, Burke-Fahn-Marsden, and Writer's Cramp Rating Scales respectively). Accordingly, participants perceived a significant worsening in their speech, writing, and walking abilities. Twenty-six of 32 participants suffered from anxiety (n = 13), obsessive-compulsive disorder (n = 9), and attention-deficit/hyperactivity disorder (n = 8). Interpretation: This study demonstrates that, unlike in the adult population, myoclonus dystonia syndrome in childhood and adolescence follows a progressive course that can be debilitating in the early stages of life. These findings, along with a high prevalence of psychiatric symptoms, highlight the need for early therapeutic interventions to prevent long-term motor and psychological sequelae.
Myoclonus Dystonia Spanish association (ALUDME). Grant Numbers: FORT23/00034, PI24/01083, PI21/00248. Agència de Gestió d'Ajuts Universitaris i de Recerca. Grant Number: 2022 FI_B 00996. Instituto de Salud Carlos III. Grant Numbers: FORT23/00034, PI21/00248, PI24/01083.
Article
Published version
English
Infants; Distonia - Aspectes genètics; Distonia - Prognosi; Adolescents; NAMED GROUPS::Persons::Age Groups::Child; DISEASES::Pathological Conditions, Signs and Symptoms::Pathologic Processes::Disease Attributes::Disease Progression; DISEASES::Nervous System Diseases::Central Nervous System Diseases::Movement Disorders::Dystonic Disorders; Other subheadings::Other subheadings::Other subheadings::/genetics; NAMED GROUPS::Persons::Age Groups::Adolescent; DENOMINACIONES DE GRUPOS::personas::Grupos de Edad::niño; ENFERMEDADES::afecciones patológicas, signos y síntomas::procesos patológicos::atributos de la enfermedad::progresión de la enfermedad; ENFERMEDADES::enfermedades del sistema nervioso::enfermedades del sistema nervioso central::trastornos del movimiento::trastornos distónicos; Otros calificadores::Otros calificadores::Otros calificadores::/genética; DENOMINACIONES DE GRUPOS::personas::Grupos de Edad::adolescente
Wiley
Developmental Medicine & Child Neurology;67(6)
https://doi.org/10.1111/dmcn.16214
info:eu-repo/grantAgreement/ES/PEICTI2021-2023/PI21%2F00248
Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
Articles científics - VHIR [1655]